Rosuvastatin Isomer-11--(3S,5S,E)-tert-butyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate
2185805-16-5
Pharmaceutical Grade
90%
Shanghai Port or Shenzhen Port
H&D
A temperature-controlled box with a capacity of up to 10g
2025-01-26
Drug impurity reference,Impurity reference,Reference substance,impurity
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Rosuvastatin isomer-10
Other Name:Rosuvastatin isomer-10;Rosuvastatin (3S,5S)-Isomer t-Butyl Ester;6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3S,5S,6E)-;Rosuvastatin (3S,5S)-Isomer t-Butyl EsterQ: What is Rosuvastatin (3S,5S)-Isomer t-Butyl Ester Q: What is the CAS Number of Rosuvastatin (3S,5S)-Isomer t-Butyl Ester;1,1-Dimethylethyl (3S,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6- heptenoate
CAS No.:2185805-16-5
Molecular Formula:C26H36FN3O6S
Molecular Weight:537.64
Categories:
Characteristics-
Density:
1.259±0.06 g/cm3(Predicted)
Boiling Point:704.2±70.0 °C(Predicted)
PKA:13.38±0.20(Predicted)
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Drug impurity reference,Impurity reference,Reference substance,impurity
-
Location:
Hengfeng Wanda (Hubei) Pharmaceutical Technology Co., LTD., Hongshan District, Wuhan City, Hubei Province, China
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
150 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2023
Company Certificates-
Brand certification certificate
-
QUALITY MANAGEMENT SYSTEM CERTIFICATE
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Upadacitinib Impurity 21-- (3R,4S)-benzyl 3-(2-chloroacetyl)-4-ethylpyrrolidine-1-carboxylate
Pharmaceutical Grade / 90%
-
-
-
-
Upadacitinib Impurity 1((3S,4S)-benzyl 3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate)
Pharmaceutical Grade / 90%
-